Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FYP19
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,835
Award facts
- Contract value 100% obligated
- $14,834.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On May 27, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $14,834.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which carries an ultimate completion date of June 17, 2025, covers the supply of Entyvio 300 mg vials. This award represents a discrete delivery order issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $499,999,999 and valid through November 2026. No set-aside designation was applied to this award.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. This delivery order for Entyvio, a prescription pharmaceutical product, exemplifies the company's core business of providing specialized pharmaceutical products to Department of Defense healthcare sites through the DLA's pharmaceutical supply program.
Quick answers
Who was awarded contract SPE2DB25FYP19?
SPE2DB25FYP19 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 27, 2025.
How much is contract SPE2DB25FYP19 worth?
The government has obligated $14,835 on SPE2DB25FYP19.
Is contract SPE2DB25FYP19 an order under another contract?
Yes. SPE2DB25FYP19 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP19 competed?
The extent of competition for SPE2DB25FYP19 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award